Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06546592
NA

Locally Optimised Contouring With AI Technology for Radiotherapy

Sponsor: Royal North Shore Hospital

View on ClinicalTrials.gov

Summary

LOCATOR is a multicentre phase II randomised clinical trial that is looking at the process of contouring in radiation treatment for breast cancer patients. This study looks at whether contouring aided by artificial intelligence (AI) is comparable in quality to that of contouring done completely manually by a radiation oncologist. We are also looking at whether AI assisted contouring saves radiation oncologists time when compared to fully manual contouring. LOCATOR uses the LOCATOR software which is an in-house software developed locally and trained on local data.

Official title: LOCATOR - Locally Optimised Contouring With AI Technology for Radiotherapy

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

444

Start Date

2025-02-11

Completion Date

2030-04-30

Last Updated

2026-01-29

Healthy Volunteers

Yes

Interventions

DEVICE

AI assisted contouring

Initial are generated automatically using software powered by artificial intelligence

Locations (3)

Western Cancer Centre Dubbo

Dubbo, New South Wales, Australia

Central West Cancer Centre

Orange, New South Wales, Australia

Department of Radiation Oncology, Royal North Shore Hospital

St Leonards, New South Wales, Australia